Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translocation t(12;13)(p13;q14) in a patient with imatinib-sensitive MDS/MPD associated with resistance to treatment: review of the literature.
Diamantopoulos PT, Athanasiadou A, Papakostas E, Gratsias N, Georgiou G, Mantzourani M, Andreopoulos G, Panagiotidis P, Aessopos A, Meletis J, Viniou N. Diamantopoulos PT, et al. Among authors: mantzourani m. Anticancer Drugs. 2011 Oct;22(9):944-7. doi: 10.1097/CAD.0b013e3283486ca4. Anticancer Drugs. 2011. PMID: 21712707 Review.
A delayed diagnosis: recurrent fever and beta thalassaemia.
Samarkos M, Mantzourani M, Nika C, Kalotychou V. Samarkos M, et al. Among authors: mantzourani m. BMJ Case Rep. 2018 Sep 30;2018:bcr2018225802. doi: 10.1136/bcr-2018-225802. BMJ Case Rep. 2018. PMID: 30275024 Free PMC article.
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Gogas H, Polyzos A, Stavrinidis I, Frangia K, Tsoutsos D, Panagiotou P, Markopoulos C, Papadopoulos O, Pectasides D, Mantzourani M, Middleton M, Vaiopoulos G, Fountzilas G. Gogas H, et al. Among authors: mantzourani m. Ann Oncol. 2006 Dec;17(12):1835-41. doi: 10.1093/annonc/mdl311. Epub 2006 Sep 15. Ann Oncol. 2006. PMID: 16980601 Free article. Clinical Trial.
Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma.
Iliakis T, Papadopoulou V, Diamantopoulos PT, Panayiotidis P, Zervakis K, Giannakopoulou N, Tilimidos G, Angelopoulou M, Siakantaris MP, Pangalis G, Mantzourani M, Variami E, Viniou NA. Iliakis T, et al. Among authors: mantzourani m. Anticancer Res. 2013 Aug;33(8):3509-14. Anticancer Res. 2013. PMID: 23898127
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Onyenadum A, Gogas H, Markopoulos C, Bafaloukos D, Aravantinos G, Mantzourani M, Koutras A, Tzorakoelefterakis E, Xiros N, Makatsoris T, Fountzilas G, Kalofonos HP. Onyenadum A, et al. Among authors: mantzourani m. J Chemother. 2007 Oct;19(5):582-9. doi: 10.1179/joc.2007.19.5.582. J Chemother. 2007. PMID: 18073159 Clinical Trial.
61 results